Get Started

PHVS

NASD Pharvaris N.V.
Oct 26, 2026 · 8:43 AM ET LAST TRADE Market Closed

$31.65 ↑ +0.24 (+0.76%) Trading Up from the previous close of $31.41

YTD change
+14.05%
vs 20-day SMA
+2.96%
vs 200-day SMA
+2.69%

Price ranges

Previous day
$30.25 $32.12
open $31.57 close $31.41
-$0.16 (-0.51%)
Today
$0.00 $0.00
$31.65
Past week
$27.74 $32.12
from $27.74 now $31.65
+$3.91 (+14.10%)
Past month
$27.68 $32.46
from $32.02 now $31.65
-$0.37 (-1.16%)
This year
$23.62 $43.25
from $27.75 now $31.65
+$3.90 (+14.05%)

Price & Performance

+2.70 (+9.40%) / 6M

$26.85$31.15$35.45$39.75Apr 27Jul 27Oct 23

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 26.8% away from all-time highs of $43.25
  • PHVS is up 14% since the beginning of the year
  • PHVS is up 38% over the past 12 months
  • PHVS is down 1% over the past 1 month
  • 3% of all PHVS investors are betting against PHVS

PHVS reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +37.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.80794
Earnings momentum +0.2% Quarterly EPS growth
Quarterly change +0.2%

Valuation

P/E ratio N/A
Enterprise value $1.8B
Beta -0.01

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$363.9M
Debt$770.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $2.2B

Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. The company was founded by Luc Dochez, Jens Schneider-Mergener, Berndt A. E. Modig, Jochen Knolle, Johannes Gerardus Christiaan Petrus Schikan, and Anne Lesage on September 30, 2015 and is headquartered in Leiden, the Netherlands.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,273.46 -2.54%
JNJ Johnson & Johnson $263.81 -1.42%
ABBV AbbVie, Inc. $285.64 +0.16%
MRK Merck & Co., Inc. $145.27 -1.34%
RHHBY Roche Holding Ltd Sponsored ADR $61.17 +2.60%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.